M16-802
ClinicalTrials.gov NCT03625505
Research payments
$2,509,690
Through program year 2020, $2,509,690 in research payments was reported against M16-802, across 172 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03625505
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,389,958 | 102 |
| 2019 | Research | $1,119,731 | 70 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Joseph Maly Louisville, KY Named on 34 payments
- Alexander Perl Philadelphia, PA Named on 23 payments
- Naval Daver Houston, TX Named on 16 payments
- Mark Litzow Rochester, MN Named on 15 payments
- Catherine Smith San Francisco, CA Named on 13 payments
- Jessica Altman Chicago, IL Named on 13 payments
- Mark Levis Baltimore, MD Named on 12 payments
- James McCloskey Hackensack, NJ Named on 10 payments
- Gary Schiller Los Angeles, CA Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.